Skip to main content
Top
Published in: World Journal of Surgery 12/2011

01-12-2011

Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer

Authors: Masaki Aizawa, Naoto Gotohda, Shinichiro Takahashi, Masaru Konishi, Taira Kinoshita

Published in: World Journal of Surgery | Issue 12/2011

Login to get access

Abstract

Background

Multimodality therapy has been used in the management of gastric cancer associated with locoregional spread. However, the accurate clinical staging still remains to be established. The neutrophil/lymphocyte ratio (NLR) in the peripheral blood is reported to be an easily assessable prognostic factor in cancer patients. We evaluated the predictive significance of the NLR and other serological parameters in patients with wall-penetrating gastric cancer.

Methods

Two hundred sixty-two patients who underwent gastric cancer surgery between 2002 and 2005 were identified retrospectively. Wall penetration was defined as wall invasion deeper than the muscularis propria (≥T2). Blood data were collected from routinely performed blood examinations before treatment and were analyzed with respect to T stage, nodal status, and histological features. A high NLR was defined as less than 3.2 based on ROC curve analysis, and the predictive value of a high NLR for T4 cancer was evaluated.

Results

Elevated levels of NLR (P = 0.004) and C-reactive protein (CRP) (P = 0.017) and the decrease in lymphocyte count (Lym, P = 0.032) and serum hemoglobin (Hb, P < 0.001) were correlated with the T stage, but there was no meaningful correlation with either positive nodal status or histological differentiation. With respect to the predictive value for stage T4, an elevated NLR (OR = 2.206, 95% CI = 1.187–4.100; P = 0.012), decrease of Hb (OR = 1.875, 95% CI = 1.005–3.500; P = 0.048), and poorly differentiated histology (OR = 3.134, 95% CI = 1.593–6.167; P = 0.001) were identified as independent predictive factors.

Conclusion

Our findings suggest that the preoperative values of the NLR may be reliable for predicting T4 disease.
Literature
1.
2.
go back to reference Noguchi Y, Yoshikawa T, Tsuburaya A et al (2000) Is gastric carcinoma different between Japan and the United States? Cancer 89:2237–2246PubMedCrossRef Noguchi Y, Yoshikawa T, Tsuburaya A et al (2000) Is gastric carcinoma different between Japan and the United States? Cancer 89:2237–2246PubMedCrossRef
4.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820PubMedCrossRef Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820PubMedCrossRef
5.
go back to reference Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef
6.
go back to reference Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730PubMedCrossRef Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730PubMedCrossRef
7.
8.
go back to reference Chen CY, Hsu JS, Wu DC et al (2007) Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic results. Radiology 242:472–482PubMedCrossRef Chen CY, Hsu JS, Wu DC et al (2007) Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic results. Radiology 242:472–482PubMedCrossRef
9.
go back to reference Habermann CR, Weiss F, Riecken R et al (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465–471PubMedCrossRef Habermann CR, Weiss F, Riecken R et al (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465–471PubMedCrossRef
10.
go back to reference Hwang SW, Lee DH, Lee SH et al (2010) Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol 25:512–518PubMedCrossRef Hwang SW, Lee DH, Lee SH et al (2010) Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol 25:512–518PubMedCrossRef
11.
go back to reference Kumano S, Murakami T, Kim T et al (2005) T staging of gastric cancer: role of multi-detector row CT. Radiology 237:961–966PubMedCrossRef Kumano S, Murakami T, Kim T et al (2005) T staging of gastric cancer: role of multi-detector row CT. Radiology 237:961–966PubMedCrossRef
12.
go back to reference de Graaf GW, Ayantunde AA, Parsons SL et al (2007) The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 33:988–992PubMedCrossRef de Graaf GW, Ayantunde AA, Parsons SL et al (2007) The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 33:988–992PubMedCrossRef
14.
15.
go back to reference Aliustaoglu M, Bilici A, Ustaalioglu BB et al (2010) The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 27(4):1060–1065PubMedCrossRef Aliustaoglu M, Bilici A, Ustaalioglu BB et al (2010) The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 27(4):1060–1065PubMedCrossRef
16.
go back to reference Crumley AB, McMillan DC, McKernan M et al (2006) An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94:1568–1571PubMed Crumley AB, McMillan DC, McKernan M et al (2006) An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94:1568–1571PubMed
18.
go back to reference Ray-Coquard I, Cropet C, Van Glabbeke M et al (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383–5391PubMedCrossRef Ray-Coquard I, Cropet C, Van Glabbeke M et al (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383–5391PubMedCrossRef
19.
go back to reference Satomi A, Murakami S, Ishida K et al (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34:69–73PubMedCrossRef Satomi A, Murakami S, Ishida K et al (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34:69–73PubMedCrossRef
20.
go back to reference Shimada H, Takiguchi N, Kainuma O et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13:170–176PubMedCrossRef Shimada H, Takiguchi N, Kainuma O et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13:170–176PubMedCrossRef
21.
go back to reference Ubukata H, Motohashi G, Tabuchi T et al (2010) Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol 102(7):742–747PubMedCrossRef Ubukata H, Motohashi G, Tabuchi T et al (2010) Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol 102(7):742–747PubMedCrossRef
22.
go back to reference Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220PubMedCrossRef Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220PubMedCrossRef
23.
go back to reference Sobin LH, Wittekind C (eds) (2010) TMN Classification of Malignant Tumours (UICC). Wiley-Blackwell, Chichester, UK Sobin LH, Wittekind C (eds) (2010) TMN Classification of Malignant Tumours (UICC). Wiley-Blackwell, Chichester, UK
24.
go back to reference Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332PubMedCrossRef Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332PubMedCrossRef
25.
go back to reference Eck M, Schmausser B, Scheller K et al (2003) Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 134:508–515PubMedCrossRef Eck M, Schmausser B, Scheller K et al (2003) Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 134:508–515PubMedCrossRef
26.
go back to reference Coussens LM, Tinkle CL, Hanahan D et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490PubMedCrossRef Coussens LM, Tinkle CL, Hanahan D et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490PubMedCrossRef
27.
go back to reference Kido S, Kitadai Y, Hattori N et al (2001) Interleukin 8 and vascular endothelial growth factor—prognostic factors in human gastric carcinomas? Eur J Cancer 37:1482–1487PubMedCrossRef Kido S, Kitadai Y, Hattori N et al (2001) Interleukin 8 and vascular endothelial growth factor—prognostic factors in human gastric carcinomas? Eur J Cancer 37:1482–1487PubMedCrossRef
28.
go back to reference Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRef Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRef
29.
go back to reference Crumley AB, Stuart RC, McKernan M et al (2008) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. J Gastroenterol Hepatol 23:e325–e329PubMedCrossRef Crumley AB, Stuart RC, McKernan M et al (2008) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. J Gastroenterol Hepatol 23:e325–e329PubMedCrossRef
30.
go back to reference McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262PubMedCrossRef McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262PubMedCrossRef
Metadata
Title
Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer
Authors
Masaki Aizawa
Naoto Gotohda
Shinichiro Takahashi
Masaru Konishi
Taira Kinoshita
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 12/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1269-2

Other articles of this Issue 12/2011

World Journal of Surgery 12/2011 Go to the issue